What Phenytoin is Used For
Phenytoin is primarily used for controlling generalized tonic-clonic (grand mal) seizures, complex partial seizures, and for preventing seizures during or after neurosurgery. 1
Primary Indications
Seizure Disorders
Phenytoin's FDA-approved indications include 1:
- Generalized tonic-clonic (grand mal) seizures - control and prevention
- Complex partial seizures (psychomotor, temporal lobe seizures)
- Neurosurgical seizure prophylaxis - prevention and treatment of seizures occurring during or following neurosurgery
Status Epilepticus
Phenytoin (or its prodrug fosphenytoin) serves as a second-line agent for status epilepticus after benzodiazepines fail. 2, 3 The 2024 ACEP guidelines establish that fosphenytoin, levetiracetam, or valproate may be used with similar efficacy (approximately 45-47% success rate) for benzodiazepine-refractory status epilepticus 3.
However, phenytoin has notable limitations in this setting:
- Only 56% success rate when combined with diazepam in the VA Cooperative Study 2
- Risk of hypotension (3.2% life-threatening hypotension) 3
- Cardiac arrhythmia risk, particularly with rapid infusion 4
- 95% of neurologists traditionally recommended it post-benzodiazepines, though newer alternatives exist 2
Mechanism of Action
Phenytoin stabilizes neuronal membranes by 1:
- Promoting sodium efflux from neurons
- Blocking voltage-gated sodium channels
- Stabilizing the threshold against hyperexcitability
- Reducing posttetanic potentiation at synapses
- Preventing cortical seizure foci from spreading to adjacent areas
Dosing Considerations
Therapeutic drug monitoring is essential because 1:
- Narrow therapeutic index (optimal levels: 10-20 mcg/mL)
- Saturable hepatic metabolism - small dose increases can cause disproportionate serum level rises
- Plasma half-life averages 22 hours (range 7-42 hours)
- Steady-state achieved in 7-10 days
- Wide interpatient variability despite equivalent dosing
Status Epilepticus Dosing
- Standard loading dose: 18-20 mg/kg IV 5, 2
- High-dose protocol: Up to 30 mg/kg recommended by Epilepsy Foundation before switching agents 5
- Infusion rate: Maximum 50 mg/min to minimize cardiac complications 4
Off-Label and Investigational Uses
While not FDA-approved, phenytoin has been studied in over 100 conditions 6, 7. Based on controlled studies, phenytoin shows probable usefulness in 6:
- Continuous muscle fiber activity syndrome
- Myotonic muscular dystrophy
- Myotonia congenita
- Cardiac arrhythmias (recently added to some labeling)
Potential dermatologic applications include 8:
- Wound healing (topical use)
- Recessive dystrophic epidermolysis bullosa
- Refractory skin ulcers
Critical Caveats
Avoid phenytoin in patients with 1:
- Known hypersensitivity to phenytoin or other hydantoins
- HLA-B*15:02 variant allele (increased Stevens-Johnson syndrome/toxic epidermal necrolysis risk) 9
- Gingival hyperplasia
- Hypersensitivity syndrome (fever, rash, lymphadenopathy)
- Purple-hand syndrome
- Drug-induced lupus
- Fetal hydantoin syndrome in pregnancy
Drug interactions are extensive - phenytoin is highly protein-bound and metabolized by saturable hepatic enzymes, making interactions with other medications, foods, and herbs clinically significant 11.